Zoetis to Participate in the Stifel 2019 Dental & Veterinary Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 20, 2019--
Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2019 Dental & Veterinary Conference on Wednesday, May 29, 2019, in New York, N.Y. Clint Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics will represent the company and respond to questions from analysts. He is scheduled to present at 10:30 a.m. ET.
Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines, medicines and diagnostics, which are complemented by genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion with approximately 10,000 employees. For more information, visit www.zoetis.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190520005058/en/
KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS VETERINARY
SOURCE: Zoetis Inc.
Copyright Business Wire 2019.
PUB: 05/20/2019 08:30 AM/DISC: 05/20/2019 08:30 AM